Drug Trial Radar · NCT00184600
Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes
Last checked: Nov 20, 2026Latest source record: Mar 9, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
708
Actual
Start
Nov 2004
Primary completion
Aug 2009
Study completion Aug 2009
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Sep 16, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is conducted in Europe. The aim of this research study is to compare the efficacy (reduction in HbA1c and in blood glucose levels) of insulin detemir, insulin aspart and biphasic insulin aspart 30, when added to current OAD (oral anti-diabetic drug) treatment in subjects with type 2 diabetes and to verify the safety of use (number and severity of episodes of hypoglycaemia, body weight and side effects).
Conditions
- Diabetes
- Diabetes Mellitus, Type 2
Interventions
biphasic insulin aspartDrug
Treat-to-target (individually adjusted dose), subcutaneously (under the skin) injection, once or twice daily plus option for insulin aspart
insulin detemirDrug
Treat-to-target (individually adjusted dose), subcutaneously (under the skin) injection, once or twice daily plus option for insulin aspart
insulin aspartDrug
Treat-to-target (individually adjusted dose), subcutaneously (under the skin) injection, twice daily plus option for insulin detemir
Primary outcomes
What the sponsor says the trial is designed to measure.
- HbA1c (Glycosylated Haemoglobin) at Month 12Time frame: Baseline, Month 12
- HbA1c (Glycosylated Haemoglobin) at Month 36Time frame: Baseline, Month 36
Locations
63 sites in 2 countries. Site status is shown where the registry gives one.
Novo Nordisk Investigational Site
Dublin, Ireland
Novo Nordisk Investigational Site
Dublin, Ireland
Novo Nordisk Investigational Site
Dublin, Ireland
Novo Nordisk Investigational Site
Galway, Ireland
Novo Nordisk Investigational Site
Aberdeen, United Kingdom
Novo Nordisk Investigational Site
Addlestone, United Kingdom
Novo Nordisk Investigational Site
Airdrie, United Kingdom
Novo Nordisk Investigational Site
Ashton-under-Lyne, United Kingdom
Novo Nordisk Investigational Site
Ayr, United Kingdom
Novo Nordisk Investigational Site
Belfast, United Kingdom
Novo Nordisk Investigational Site
Belfast, United Kingdom
Novo Nordisk Investigational Site
Belfast, United Kingdom
Novo Nordisk Investigational Site
Berkshire, United Kingdom
Novo Nordisk Investigational Site
Birmingham, United Kingdom
Novo Nordisk Investigational Site
Birmingham, United Kingdom
Novo Nordisk Investigational Site
Bournemouth, United Kingdom
Novo Nordisk Investigational Site
Bradford, United Kingdom
Novo Nordisk Investigational Site
Bristol, United Kingdom
Novo Nordisk Investigational Site
Bury St Edmunds, United Kingdom
Novo Nordisk Investigational Site
Cambridge, United Kingdom
Novo Nordisk Investigational Site
Colchester, United Kingdom
Novo Nordisk Investigational Site
Coventry, United Kingdom
Novo Nordisk Investigational Site
Crawley, United Kingdom
Novo Nordisk Investigational Site
Derby, United Kingdom
Novo Nordisk Investigational Site
Dundee, United Kingdom
Novo Nordisk Investigational Site
Edinburgh, United Kingdom
Novo Nordisk Investigational Site
Exeter, United Kingdom
Novo Nordisk Investigational Site
Gillingham, United Kingdom
Novo Nordisk Investigational Site
Glasgow, United Kingdom
Novo Nordisk Investigational Site
Guildford, United Kingdom
Novo Nordisk Investigational Site
Haywards Heath, United Kingdom
Novo Nordisk Investigational Site
Headington, United Kingdom
Novo Nordisk Investigational Site
High Wycombe, United Kingdom
Novo Nordisk Investigational Site
Hull, United Kingdom
Novo Nordisk Investigational Site
Kettering, United Kingdom
Novo Nordisk Investigational Site
Leeds, United Kingdom
Novo Nordisk Investigational Site
Leicester, United Kingdom
Novo Nordisk Investigational Site
Leicester, United Kingdom
Novo Nordisk Investigational Site
Liverpool, United Kingdom
Novo Nordisk Investigational Site
Liverpool, United Kingdom
Showing 40 of 63 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.